Literature DB >> 6247826

Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane.

E J Dubovi, J D Geratz, R R Tidwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6247826     DOI： 10.1016/0042-6822(80)90207-x

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  16 in total

Review 1.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Suppression of respiratory syncytial virus infection in cotton rats by bis(5-amidino-2-benzimidazolyl)methane.

Authors:  R R Tidwell; J D Geratz; W A Clyde; K U Rosenthal; E J Dubovi
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

3.  Inhibition of respiratory syncytial virus-host cell interactions by mono- and diamidines.

Authors:  E J Dubovi; J D Geratz; S R Shaver; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

4.  Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.

Authors:  J E Hall; J E Kerrigan; K Ramachandran; B C Bender; J P Stanko; S K Jones; D A Patrick; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

5.  Effect of synthetic protease inhibitors of the amidine type on cell injury by Rickettsia rickettsii.

Authors:  D H Walker; R R Tidwell; T M Rector; J D Geratz
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.

Authors:  Philip J Budge; Yeqiang Li; Judy A Beeler; Barney S Graham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Analysis of proteins synthesized in respiratory syncytial virus-infected cells.

Authors:  E J Dubovi
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro.

Authors:  F Kawana; S Shigeta; M Hosoya; H Suzuki; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

9.  Effect of treatment with a cationic antiviral compound on acute infection with bovine viral diarrhea virus.

Authors:  Benjamin W Newcomer; M Shonda Marley; Patricia K Galik; Yijing Zhang; Kay P Riddell; David W Boykin; Arvind Kumar; Leah A Kuhnt; Julie A Gard; M Daniel Givens
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

10.  Orally active fusion inhibitor of respiratory syncytial virus.

Authors:  Christopher Cianci; Kuo-Long Yu; Keith Combrink; Ny Sin; Bradley Pearce; Alan Wang; Rita Civiello; Stacey Voss; Guangxiang Luo; Kathy Kadow; Eugene V Genovesi; Brian Venables; Hatice Gulgeze; Ashok Trehan; Jennifer James; Lucinda Lamb; Ivette Medina; Julia Roach; Zheng Yang; Lisa Zadjura; Richard Colonno; Junius Clark; Nicholas Meanwell; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.